excluding loss (gain) on sale/exchange of long-lived assets, impairments, the revenue impact of changes in the fair value of derivative instruments prior to settlement and certain other items that
even in the context of significant treatment effects, “reliable predictors of (individual) response to treatment have not been demonstrated”. The authors of that review note that in the majority of countries, including those of high-income, most intervention is conducted by non-specialists, and ...